Ym mis Rhagfyr, cyhoeddodd Llywodraeth yr Alban ei bod wedi cytuno ar fynediad dros dro at y meddyginiaethau ffibrosis systig Orkambi a Symkevi, a yw'r Gweinidog wedi cael unrhyw drafodaethau pellach o ran cytundeb ar gyfer trefniant tebyg i Gymru?
The All Wales Medicine Strategy Group contacted Vertex Pharmaceuticals again in November 2018 but the company has still not submitted Orkambi® for appraisal. I understand that Vertex has agreed to submit Orkambi® for re-appraisal and Symkevi® for appraisal by the Scottish Medicines Consortium, and that clinicians will use the Scottish equivalent of our Individual Patient Funding Request process to access these medicines. The company has not extended the same proposal to the NHS in Wales.